Exonic sequencing and MLH3 gene expression analysis of breast cancer patients
Copyright policy )Exonic sequencing and MLH3 gene expression analysis of breast cancer patients
Breast cancer is the most common cancer in women worldwide. Detection of breast cancer susceptibility genes is an important issue. Also, MLH3 is a DNA mismatch repair gene and mutation in this gene is harmful in different cancers. This study aimed to use exome sequencing to uncover previously undetected breast cancer-predisposing variants. Also, we investigated the MLH3 gene expression of breast cancer patients which can be a breast cancer susceptibility gene. A total of 80 samples including 40 paired normal and cancer tissue samples were collected at Zheen International Hospital, Erbil, Iraq. Exome sequencing was used to identify mutations. Different in silico tools were used to predict the effect of mutation on the structural features or protein function. Real-time PCR was used for assessing the expression of MLH3 in breast cancer patients. We identified 26 variants in breast cancer patients, 22 inherited variants were found in MLH3, CHECK2, BRCA1, BRCA2, BLM, TP53, MSH6, NBN and PTEN genes and 4 somatic variants were found in PALB2, RAD50 and RBM10 genes. It was found that the expression of the MLH3 gene in tumor samples was significantly down-regulated compared with normal tissues. Statistically, high significance was found. The decreased expression of MLH3 was significant in all ranges of ages and all breast cancer types. Also, the expression of MLH3 decreased significantly in patients with breast cancer grades of II and III. In conclusion, MLH3 can be used as a susceptibility gene especially in grades II and III of breast cancer.
- Gaziantep University Turkey
Adult, BRCA2 Protein, RecQ Helicases, BRCA1 Protein, Reverse Transcriptase Polymerase Chain Reaction, Breast Neoplasms, Middle Aged, Gene Expression Regulation, Neoplastic, MutL Proteins, Mutation, Exome Sequencing, Humans, Female, Genetic Predisposition to Disease, Neoplasm Grading, Fanconi Anemia Complementation Group N Protein
Adult, BRCA2 Protein, RecQ Helicases, BRCA1 Protein, Reverse Transcriptase Polymerase Chain Reaction, Breast Neoplasms, Middle Aged, Gene Expression Regulation, Neoplastic, MutL Proteins, Mutation, Exome Sequencing, Humans, Female, Genetic Predisposition to Disease, Neoplasm Grading, Fanconi Anemia Complementation Group N Protein
citations This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).4 popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network.Top 10% influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).Average impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network.Average
Citations provided by BIP!Popularity provided by BIP!